Wiseman Susan

General Counsel Wiseman sold 35.0K BRZE shares at $20.29 on 2026-04-09 ($710.2K); stock now -44.1% from 52-week high, 5 prior BRZE sells 90%-well-timed, company unprofitable.

Susan Wiseman, General Counsel, sold 35,000 shares at $20.29 for $710,150.00, reducing her holdings by 14.3%. The stock has fallen -44.1% from its 52-week high and is down -29.3% over the past 90 days, while her prior 5 sales at BRZE all showed negative 90-day returns with a 100% well-timed rate—a pattern suggesting consistent decision-making ahead of declines. Set against the company's unprofitability ($-36.0M net income in latest quarter) and stock weakness, the sale aligns with her historical timing pattern at this ticker. Current price of $20.61 sits in the lower half of the 52-week range, and the recent 90-day decline of -29.3% extends a longer downward trajectory in which her prior sales have fared well when measured at the 90-day mark.

General Counsel Wiseman sold 14,000 shares at avg $45.52 on 2025-01-06; holds 199.5K post-sale.

Susan Wiseman, General Counsel, executed 2 separate sales totaling 14,000 shares for $637,303.37, reducing her stake by 6.6% to 199.5K shares. Wiseman's cross-ticker track record shows a 75.00% well-timed sell rate across 5 prior open-market sales, with 3 of 4 measurable same-ticker sales at BRZE showing negative 90-day returns (well-timed at 75%). The current sale occurs at $45.52 blended average price, 3.1% above the current market price of $44.15 but 23.8% below the 52-week high of $59.73. BRZE remains unprofitable (full-year net income $-27,911,000.00) despite strong revenue growth of 32.7% annually, creating elevated execution risk for a company trading at a compressed valuation. The sale timing warrants observation given the insider's demonstrated pattern of well-timed exit execution at this specific ticker.

General Counsel sells 41,210 shares of BRZE at $45.09 on 2024-12-18; holds 199,520 shares post-transaction

Susan Wiseman, General Counsel of Braze, sold 41,210 shares at $45.09, reducing her stake from 240,730 to 199,520 shares, a -17.1% reduction. Her prior four sales at BRZE show 3 of 4 were well-timed at the 90-day mark (negative subsequent returns), though her cross-ticker track record over all tickers shows a 75.00% well-timed sell rate with an average 90-day return of -11.9%, suggesting a pattern of selling ahead of declines. The company is currently unprofitable with net income of $-27,911,000.00 against $152,052,000.00 in latest quarterly revenue, though full-year revenue growth stands at +32.7%, indicating high growth offset by near-term profitability challenges. Note: This filing involves a derivative-conversion transaction; the insider's complete position in derivative securities (Form 4 Table II) is not yet reflected in available data and should be reviewed for full position context.

General Counsel Wiseman sells 12,000 BRZE shares (2 sales at blended $42.48) as stock down -38.1% from 52-week high

Wiseman sold 12,000 shares across two separate transactions on 2024-08-01, totaling $509,817.39 at a blended average price of $42.48, reducing her holdings by 5.3% to 214,340 shares. The timing is notable: the stock now trades at $36.98, down 38.1% from its 52-week high of $59.73, and has declined 12.1% over the past 90 days. While Wiseman's cross-ticker track record shows a 50.00% well-timed rate across 2 prior sells, her same-ticker history at BRZE reveals mixed results—one prior sell yielded a -5.4% 90-day return (well-timed) and another yielded +8.4% (poorly timed). The company remains unprofitable on a full-year basis (net income of $-35.6M against $135.5M in latest-quarter revenue) despite 32.7% annual revenue growth. This sale reflects a material reduction in a senior executive's stake at a mid-stage growth company facing continued profitability challenges.